Paul Liknaitzky is Head of the Clinical Psychedelic Lab at Monash University, and Chief Principal Investigator on a program of psychedelic trials. He is a Senior Research Fellow within the Dept of Psychiatry at Monash University, and has an Honours degree in Neuroscience and a PhD in Psychology from the University of Melbourne. In Australia, he is an Investigator on many of the country’s initial psychedelic trials across multiple institutions, has coordinated several psychedelic therapist training and supervision programs, and leads the first clinical psychedelic lab. His work is focused on a rigorous program of research in clinical psychedelics that seeks to innovate on treatment design, evaluate therapeutic effects, mitigate known risks, explore potential drawbacks, and understand therapeutic mechanisms.